|
EP0807172A1
(en)
*
|
1995-01-30 |
1997-11-19 |
HYBRIDON, Inc. |
Human immunodeficiency virus transcription inhibitors and methods of their use
|
|
AU2001250572A1
(en)
*
|
2000-04-07 |
2001-10-23 |
Epigenomics Ag |
Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations
|
|
US20070093437A1
(en)
*
|
2001-05-18 |
2007-04-26 |
Sirna Therapeutics, Inc. |
Rna interference mediated inhibition of xiap gene expression using short interfering nucleic acid (sina)
|
|
WO2009028945A2
(en)
*
|
2007-08-30 |
2009-03-05 |
Academisch Ziekenhuis Bij De Universiteit Van Amsterdam |
Pathways involved in arteriogenesis and uses thereof
|
|
WO2012068630A1
(en)
*
|
2010-11-26 |
2012-05-31 |
The University Of Melbourne |
Methods and compositions comprising antagonists of type 1 interferon-mediated signalling for reducing a neuroinflammatory response in the central nervous system following a stroke
|
|
WO2013151664A1
(en)
*
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins
|
|
KR20160027968A
(ko)
*
|
2013-06-07 |
2016-03-10 |
라나 테라퓨틱스, 인크. |
Foxp3 발현을 조절하기 위한 조성물 및 방법
|
|
WO2016009430A1
(en)
*
|
2014-07-14 |
2016-01-21 |
Yeda Research And Development Co. Ltd |
Reduction of aging-induced type i interferon signaling at the brain's choroid plexus or within the cns for treatment of disease or injury of the cns
|
|
CN104312973B
(zh)
*
|
2014-10-09 |
2017-04-26 |
北京师范大学 |
I型干扰素在诱导atx蛋白表达中的应用
|
|
CN107429250B
(zh)
*
|
2015-04-03 |
2022-03-01 |
Ionis制药公司 |
用于调节tmprss6表达的化合物和方法
|
|
EP3419643A4
(en)
*
|
2016-02-24 |
2020-04-01 |
Children's Hospital of Eastern Ontario Research Institute Inc. |
SMC COMBINATION THERAPY FOR TREATING CANCER
|
|
US20200190587A1
(en)
*
|
2017-04-28 |
2020-06-18 |
Avellino Lab Usa, Inc. |
Methods for Detecting Alleles Associated with Keratoconus
|
|
EP3672579A4
(en)
*
|
2017-10-10 |
2021-06-23 |
University of Virginia Patent Foundation |
COMPOSITIONS AND METHODS OF TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHICAL ATROPHY
|
|
AU2019218987B2
(en)
*
|
2018-02-12 |
2025-04-24 |
Ionis Pharmaceuticals, Inc. |
Modified compounds and uses thereof
|
|
SG11202101946YA
(en)
*
|
2018-09-18 |
2021-04-29 |
I Mab Biopharma Hangzhou Co Ltd |
Anti-ifnar1 antibodies for treating autoimmune diseases
|
|
WO2020072991A1
(en)
*
|
2018-10-05 |
2020-04-09 |
Ionis Pharmaceuticals, Inc. |
Modified oligomeric compounds and uses thereof
|
|
US12281305B2
(en)
*
|
2018-11-21 |
2025-04-22 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for reducing prion expression
|
|
TW202536179A
(zh)
*
|
2019-03-29 |
2025-09-16 |
美商Ionis製藥公司 |
用於調節ube3a-ats之化合物及方法
|
|
US20220372560A1
(en)
*
|
2019-10-30 |
2022-11-24 |
Takeda Pharmaceutical Company Limited |
Methods for detecting oligonucleotides
|